20494 ⎘
Medicinal preparations containing organic active ingredients Tetracyclines
BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#602Inhibition of multiple pathogenic agents using bithionol
#603Regenerated oxidized celulose based hemostatic materialcontaining antifibrolytic agents
#604METHODS TO ENHANCE BIOAVAVAILABILITY OF ORGANIC SMALL MOLECULES AND DEPOSITED FILMS MADE THEREFROM
#605Patient treatment via teratogenic pharmaceutical compounds
#606Polylactide compositions and uses thereof
#607SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
#608SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE
#609DUAL LOADED LIPOSOMAL NANOPARTICLES
#610Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
#611Positionable delivery device and method
#612COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING LYME DISEASE
#613Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
#614TRANSDERMAL FORMULATIONS FOR DELIVERY OF DOXYCYCLINE, AND THEIR USE IN THE TREATMENT OF DOXYCYCLINE-RESPONSIVE DISEASES AND CONDITIONS
#615TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
#616METHOD OF PREPARING NANOPARTICULATE TOPICAL COMPOSITION
#617Treatment for Spirochete borne illness
#618METHODS AND KITS FOR SELECTING TREATMENT FOR ORAL INFECTIONS
#619PHARMACEUTICAL COMPOSITION, SUBSTRATE COMPRISING A PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION
#620HTS Assay for Identifying Small Molecule Inhibitors of RAD52 and Uses of Identified Small Molecule Inhibitors for Treatment and Prevention of BRCA-Deficient Malignancies
#621Modified release doxycycline composition
#622Liposome loading
#623ELASTIC ANTIMICROBIAL FILM AND SOCKET MADE THEREFROM
#624Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#625Topical tetracycline compositions
#626Prodrugs activated by caspase
#627Pharmaceutical tetracycline composition for dermatological use
#628Meloxicam for the treatment of respiratory diseases in pigs
#629Use of levocetirizine and montelukast in the treatment of traumatic injury
#630Antimicrobial alpha-helical cationic polypeptides
#631Efflux-pump inhibitors and therapeutic uses thereof
#632Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
#633Compositions and Methods employing Wolbachia FtsZ as a target for Albendazole sulfone
#634Antibiotic sensitivity-restoring and photosensitive agents
#635Combination therapy for skin disorders
#6369-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
#637MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES
#638TREATMENT OF CONDITIONS RELATED TO SHOCK
#639Method for healing of an infected acne lesion without scarring
#640PERIODONTIC TREATMENT AND METHOD
#641MINOCYCLINE COMPOUNDS FOR BIODEFENSE
#642Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
#643Vitamin functionalized gel-forming block copolymers for biomedical applications
#644METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
#645SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND
#646Use of alginate oligomers in combating biofilms
#647TIGECYCLINE COMPOSITION FOR INJECTION
#648TETRACYCLINE COMPOSITIONS
#649Compositions and methods for treating rosacea and acne
#6509-aminomethyl minocycline compounds and uses thereof
#651Frankiamicin A compositions and methods
#652Compositions and methods employing FtsZ as a target for Albendazole sulfone
#653Nanoparticulate composition
#654PREVENTION OF AND RECOVERY FROM DRUG-INDUCED OTOTOXICITY
#655Polymorphic forms of minocycline base and processes for their preparation
#656Microbiota restoration therapy (MRT), compositions and methods of manufacture
#657Technology for the Preparation of Microparticles
#658Potentiated antimicrobial agents
#659TETRACYCLINE COMPOUNDS HAVING TARGET THERAPEUTIC ACTIVITIES
#660Minocycline compounds and methods of use thereof
#661Method of treating type I diabetes using an AAV vector encoding uracortin 2
#662Inhibition and diagnostics of emerging tetracycline resistance enzymes
#663Methods for treating pulmonary non-tuberculous mycobacterial infections
#664Vascular calcification
#665Crystalline isoxazole hydroxamic acid compounds
#666Composition and method for treating bipolar disorder
#667Treatment of rhinosinusitis with P-glycoprotein inhibitors
#668Enhancement of antibiotic efficacy
#669Topical tetracycline compositions
#670Polymer solution for visco-supplementation
#671COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#672Compositions and methods for treating an infection
#6739-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (UTI) treatment
#674Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
#675PHARMACEUTICAL FORMULATIONS FOR TREATING SKIN DISORDERS AND METHODS FOR FABRICATING AND USING THEREOF
#676Hemostatic devices and methods of use
#677Hemostatic devices and methods of use
#678METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION
#679Pharmaceuticals for Oral Delivery
#680Implantable cellular and biotherapeutic agent delivery canister
#681SUBSTITUTED TETRACYCLINE COMPOUNDS
#682TREATMENT OF RHEUMATOID ARTHRITIS
#683Decubitus Ulcer Salve
#684C7-Fluoro Substituted Tetracycline Compounds
#685Composition comprising a compound from the family of avermectins and doxycycline for the treatment of rosacea
#686Tigecycline compositions and methods of preparation
#687RESIDENCE STRUCTURES AND RELATED METHODS
#688Signalling system
#689ENCAPSULATING LIPOSOMES
#690Methods for the treatment of peri-implantitis
#691Polymer coating compositions and coated products
#692Compositions and methods for treating an infection
#693COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS
#694FORMULATIONS FOR HISTATIN THERAPEUTICS
#695System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
#696COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#697PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING
#698Multi-ingredient pharmaceutical composition for use in cancer therapy
#699Antibody Drug Conjugates
#700Yeast-MUC1 immunotherapeutic compositions and uses thereof
#701Tumor infiltrating cells engineered to express a pro-inflammatory polypeptide
#702Potentiated antimicrobial agents
#703DENDRIMERS FOR SUSTAINED RELEASE OF COMPOUNDS
#704Preparation and biological evaluation of viridicatumtoxin analogs
#705Antibiotic compositions for treating bacterial infections
#706NOVEL PARASITE THERAPY
#707Sulfur(VI) fluoride compounds and methods for the preparation thereof
#708STABLE PHARMACEUTICAL COMPOSITIONS
#709Topical minocycline compositions and methods of using the same
#710Transcriptional signature for chlamydial pelvic inflammatory disease
#711Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition
#712Controlled Release Doxycycline
#713Oil foamable carriers and formulations
#714Combination therapies with anti-CD38 antibodies
#715METHODS FOR COATING IMPLANT SURFACES TO TREAT SURGICAL INFECTIONS
#716METHODS OF TREATING OVARIAN CANCER
#717ANTIBIOTIC PROTOCELLS AND RELATED PHARMACEUTICAL FORMULATIONS AND METHODS OF TREATMENT
#718PHARMACEUTICAL FORMULATIONS FOR TREATING SKIN DISORDERS AND METHODS FOR FABRICATING AND USING THEREOF
#719Antimicrobial solutions with enhanced stability
#720USE OF TRPA1 ANTAGONISTS TO PREVENT OR TREAT INFECTIONS CAUSED BY BIOLOGICAL-WARFARE AGENTS
#721BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
#722Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#723Self-assembled residence devices and related methods
#724Enteric elastomers
#725TREATMENT OF CONDITIONS RELATED TO SHOCK
#726Inorganic-organic hybrid compound
#727Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
#728Residence structures and related methods
#729Method and system for reducing the likelihood of colorectal cancer in a human being
#730PHARMACEUTICAL COMPOSITION CAPABLE OF ACCELERATED PENETRATION INTO AFFECTED AREA
#731Small molecule efflux pump inhibitors
#732Methods and compounds to inhibit enveloped virus release
#733Metakaryocidal treatments
#734Technology for the Preparation of Microparticles
#735Method and system for reducing the likelihood of a spirochetes infection in a human being
#736Modified release doxycycline composition
#737Use of levocetirizine and montelukast in the treatment of traumatic injury
#738Pharmaceuticals for oral delivery
#739Microbiota restoration therapy (MRT), compositions and methods of manufacture
#740Topical film delivery system
#741Topical film delivery system
#742Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
#743Method of Treating Adhesion by Altering an Epithelial to Mesenchymal Transition
#744METHODS AND COMPOSITIONS FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER
#745Activity-dependent expression of nucleic acids
#746Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment
#747Combination therapy for skin disorders
#748CARRIER AND PHARMACEUTICAL COMPOSITIONS FOR INTRASINAL DELIVERY AND USES THEREOF
#749Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
#750INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS
#751BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#752Polylactide compositions and uses thereof
#753METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
#754Molecules that inhibit efflux pumps in multi-drug resistant bacteria and uses thereof
#755Sustained-release drug carrier composition
#756USE IN SINGLE PILL/TABLET/CAPSULE OF MINOCYCLINE, FLUCONAZOLE AND ATORVASTATIN IN THE TREATMENT OF MULTIPLE SCLEROSIS
#757Topical pharmaceutical compositions for treatment of pilonidal sinus wounds
#758Liposome loading
#759CALCITONIN PRODUCTS AND THERAPIES FOR TREATING INFLAMMATORY OR DEGENERATIVE DISEASES
#760Positionable delivery device and method
#761pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
#7624-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS
#763SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND
#764THERAPY REGIMEN FOR TREATING SEVERE ACNE RELATED DISEASES
#765Hypromellose-graft-chitosan and methods thereof for sustained drug delivery
#766METHODS FOR GENERATING NEW HAIR FOLLICLES, TREATING BALDNESS, AND HAIR REMOVAL
#767ELEVATED CCL19 AFTER COMPLETION OF THERAPY FOR ACUTE LYME DISEASE IDENTIFIES PATIENTS AT RISK FOR DEVELOPMENT OF POST-TREATMENT LYME DISEASE SYNDROME WHO WILL BENEFIT FROM FURTHER ANTIBIOTIC THERAPY
#768Antibiotic sensitivity-restoring and photosensitive agents
#769Photodynamic therapy for treating infection using chitosan and tetracycline
#770Methods of treating fragile X associated disorders, ADHD, and autism spectrum disorder
#771Pharmaceuticals for oral delivery
#772Pharmaceutical compositions for minocycline
#773NOVEL ENCAPSULATION OF FLUORESCENT, PHOTO-SENSITIVE, OR OXYGEN-SENSITIVE ACTIVE INGREDIENT FOR TOPICAL APPLICATION
#774Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
#775Pharmaceutical tetracycline composition for dermatological use
#776ORAL AND INJECTABLE FORMULATIONS OF TETRACYCLINE COMPOUNDS
#777COMPOSITION OF EXCIPIENTS AND PHARMACEUTICAL FORMS WITH SUSTAINED RELEASE AND INCREASED BIOAVAILABILITY OF ANTIBACTERIAL DRUGS, ANTICOCCIDIAL DRUGS AND OTHER DRUGS FOR COMMERCIAL POULTRY AND PIGS
#778DENDRIMERS FOR SUSTAINED RELEASE OF COMPOUNDS
#779N-alkyl lactam ethers, and compositions and uses thereof
#780Hydrogel formulation for dermal and ocular delivery
#781Method of Treating Periodontal Disease by Altering an Epithelial to Mesenchymal Transition
#782Controlled Release Doxycycline
#783NOVEL PARASITE THERAPY
#784Method of Treating Endometrial Tissue Disease by Altering an Epithelial to Mesenchymal Transition
#785Technology for the Preparation of Microparticles
#786Minocycline compounds and methods of use thereof
#787Pharmaceutical combinations for the treatment of cancer
#788Polymyxin derivatives and their use in combination therapy together with different antibiotics
#789Method to kill pathogenic microbes in a patient
#790MATERIAL TO PREVENT POST SURGICAL INFECTION
#791Treatment of rhinosinusitis with P-glycoprotein inhibitors
#792COMPOSITIONS AND METHODS FOR THE TREATMENT OF BURKHOLDERIA INFECTIONS
#793Diagnosis of respiratory tract infectious disease using urine specimens
#794Doxycycline composition
#795Pharmaceutical composition of doxycycline with reduced food effect
#796Tabletting Process
#797FORMULATIONS FOR CONTROL AND PREVENTION OF PERIODONTAL AND PERIMPLANT DISEASES AND OTHER DISEASES AND CONDITIONS OF THE MOUTH, AND SUPRA AND SUB-GINGIVAL DELIVERY METHODS AND SYSTEMS FOR SUCH FORMULATIONS
#798Prodrugs activated by caspase
#799Tigecycline compositions and methods of preparation
#800TREATMENT OF CONDITIONS RELATED TO SHOCK
#801STABLE PHARMACEUTICAL COMPOSITIONS
#802LOW DOSE PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE
#803LOW DOSE PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE
#804MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE
#805Methods of treating acne
#806Modified release doxycycline composition
#807DIRECT MEDICAMENT PERIODONTAL DELIVERY METHOD AND ASSEMBLY FOR REDUCTION OF THE SYSTEMIC INFLAMMATORY MARKERS
#808Rhomboid Proteins and Uses Thereof
#809METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT
#810POLYMER DRUG CONJUGATES FOR THE TREATMENT OF AMYLOIDOSIS
#811Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
#812Once Daily Formulations of Tetracyclines
#813Doxycycline Formulations, and Methods of Treating Rosacea
#814Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#815Controlled release doxycycline
#816Controlled release doxycycline
#817Controlled release doxycycline
#818Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
#819PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE WITH REDUCED FOOD EFFECT
#820Antimicrobial catheters
#821Stable tigecycline composition
#822for the treatment of solid tumors in humans
#823TREATMENT OF RHEUMATOID ARTHRITIS
#824C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS
#825Methods for modulating chemotherapeutic cytotoxicity
#826USE IN ONE PILL TABLET CAPSULE MINOCYCLINE ACYCLOGUANOSINE ATORVASTATIN AND VITAMIN D3 IN THE TREATMENT OF RHEUMATOID ARTHRITIS
#827Minoxidil for suppressing androgen receptor function
#828Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
#829COMPOSITIONS FOR INHIBITING INFLAMMATION IN A SUBJECT WITH A SPINAL CORD INJURY AND METHODS OF USING THE SAME
#830Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
#831Treatment of multiple sclerosis
#832METHODS OF INCREASING ORAL BIOAVAILABILITY OF TETRACYCLINES
#833Minocycline Derivatives
#834SUBSTITUTED TETRACYCLINE COMPOUNDS FOR TREATMENT OF BACILLUS ANTHRACIS INFECTIONS
#835Chelated drug delivery systems
#836SYSTEM, RETAINER AND METHOD OF PROVIDING THERAPEUTIC TREATMENT FOR ACNE
#837Methods and compositions for increasing antibiotic activity
#838Dental and medical devices with light source and antimicrobial solution
#839Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#840Medical device coatings
#841Pharmaceutical composition of doxycycline with reduced food effect
#842Combinatorial compositions and methods for treatment of melanoma
#843Compounds, compositions, and methods for preventing metastasis of cancer cells
#844Detection of DNA sequences as risk factors for HIV infection
#845Combination Therapy for the Treatment of Nosocomial Pneumonia
#846Composition for treatment of pathogens that are resistant to tetracyclines
#847Technology for the Preparation of Microparticles
#848Use of levocetirizine and montelukast in the treatment of traumatic injury
#849Dental compositions
#850PHARMACEUTICALLY ACCEPTABLE DOSAGE FORM COMPRISING RELEASE OF MULTIPLE DRUGS FROM SINGLE ORAL DOSAGE FORM
#851Methods of using substituted tetracycline compounds to modulate RNA
#852Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#853METHODS AND COMPOSITIONS FOR PRESERVING THE MUCOSAL BARRIER
#854Methods of treating acne
#855Small molecule drug release from in situ forming degradable scaffolds incorporating hydrogels and bioceramic microparticles
#856Polymer coating compositions and coated products
#857Microbial-relief composition
#858Methods and compositions for administering an active agent to the pleura of a patient
#859Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#8609-SUBSTITUTED MINOCYCLINE COMPOUNDS
#861TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#862Combination therapies with anti-CD38 antibodies
#863Doxycycline Formulations, and Methods of Treating Rosacea
#864Microbiota restoration therapy (MRT), compositions and methods of manufacture
#865Alginate oligomers for use in overcoming multidrug resistance in bacteria
#866Vitamin functionalized gel-forming block copolymers for biomedical applications
#867LEUKOCYTES AS DELIVERY CELLS FOR IMAGING AND DISEASE THERAPY
#868Combinations with a backbone-cyclized peptide
#869ANTIPARASITIC POLYANHYDRIDE NANOPARTICLES
#870Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
#871Compositions and methods for the treatment of bone voids and open fractures
#872SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES
#873Tigecycline composition for injection
#874Compositions comprising macrolide and tetracycline and their uses
#875Topical tetracycline compositions
#876TETRACYCLINE COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
#877Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#878Sustained-release drug carrier composition
#879USE OF TETRACYCLINE COMPOSITIONS FOR WOUND TREATMENT AND SKIN RESTORATION
#880CORNEAL SHAPING
#881Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
#882Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
#883POLYMERIC DRUG DELIVERY SYSTEM FOR TREATING SURGICAL COMPLICATIONS
#884Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
#885AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#886ANTIMICROBIAL COMPOSITIONS AND METHODS FOR PREVENTING INFECTION IN SURGICAL INCISION SITES
#887Method to reduce SLOSH energy absorption and its damaging effects through the reduction of inelastic collisions in an organism
#888TETRACYCLINE COMPOUNDS HAVING TARGET THERAPEUTIC ACTIVITIES
#889Tigecycline compositions and methods of preparation
#890Dendrimer based nanodevices for therapeutic and imaging purposes
#891Heparosan-Multimolecular Assembly Drug Delivery Compositions and Methods of Making and Using Same
#892System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
#893Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
#894SYSTEMIC DELIVERY AND REGULATED EXPRESSION OF PARACRINE GENES FOR CARDIOVASCULAR DISEASES AND OTHER CONDITIONS
#895Oil and liquid silicone foamable carriers and formulations
#896ANTIMICROBIAL ACCESSORY FOR AN IMPLANTABLE MEDICAL DEVICE
#897COATED PHARMACEUTICAL CAPSULE DOSAGE FORM
#898Pharmaceutical removal of neuronal extensions from a degenerating disc
#899Tabletting Process
#900Tetracycline compositions